Deoxysphingolipids Upregulate MMP-1, Downregulate TIMP-1, and Induce Cytotoxicity in Human Schwann Cells

Area of Science:

• Biochemistry
• Neuroscience
• Endocrinology

Background:

• Sphingolipids are vital cell membrane components.
• Plasma deoxysphingolipids (DSLs) are elevated in diabetic patients and linked to neuropathy.
• The causal role of DSLs in diabetic neuropathy is unclear.

Purpose of the Study:

• To investigate the effect of DSLs on matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMPs) in human Schwann cells.
• To determine if DSL levels in lipoproteins differ between type 2 diabetes mellitus (T2DM) patients with and without neuropathy.
• To assess the impact of DSL-containing lipoproteins on Schwann cell activity.

Main Methods:

• Quantification of protein secretion, gene expression, and collagenase activity.
• Cytotoxicity assays on human Schwann cells exposed to DSLs.
• Lipidomic analysis of VLDL, LDL, HDL2, and HDL3 from T2DM patients with or without neuropathy.

Main Results:

• DSLs upregulated MMP-1, downregulated TIMP-1, and induced cytotoxicity in Schwann cells.
• HDL2 from T2DM patients with neuropathy had significantly higher DSL levels.
• HDL2 from T2DM patients with neuropathy enhanced MMP-1 upregulation, TIMP-1 downregulation, and collagenase activity in Schwann cells.

Conclusions:

• DSLs show a potential causal relationship with diabetic neuropathy.
• DSL-enriched HDL2 from T2DM patients with neuropathy is more potent in stimulating collagenase activity.
• This study highlights DSLs as a potential therapeutic target for diabetic neuropathy.